
News
Take a closer look at what we’re doing across here in Ireland and across Teva worldwide
News
Featured stories
Media Resources



Date of preparation: June 2022
Reference: COB-IE-NP-00070
Contacts
Website Information
Reporting Side Effects
Side effects can be reported to Teva using the Reporting Side Effects Form or via email uk.safety@tevauk.com or also directly via the Yellow Card Scheme here. By reporting side effects, you can help provide more information on the safety of a medicine.
Registered in Ireland No. 366280. Registered office: Teva Pharmaceuticals Ireland, Unit 301, Waterford Industrial Park, Co Waterford, X91 WK68 Republic of Ireland. Copyright © 2023 Teva Pharmaceuticals Ireland